Cognitact Limited

【康至德】將前沿研究成果轉化為腦退化症的風險預測、診斷和疾病監測工具，利用血液在症狀出現階段之前檢測出認知障礙症。

At Cognitact, we are translating cutting-edge research efforts into a risk prediction, diagnostic and disease monitoring tool for dementia, aiming to detect Alzheimer's disease before its symptomatic stage using blood.